Erste Group downgraded Novo Nordisk (NVO) to Hold from Buy.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Eli Lilly’s Weight Loss Drug Mounjaro Finds its Place in Hong Kong
- Novo Nordisk’s (NYSE:NVO) GLP-1 Drugs Could Help Fight Alzheimer’s Disease
- Boeing union rejects latest offer, Tesla reports Q3 beat: Morning Buzz
- Novo Nordisk asks FDA to ban cheap copies of Wegovy, Ozempic, CNBC reports
- Novo Nordisk (NYSE:NVO) Seeks Ban on Weight Loss Drug Copies